ѻý

1 Psilocybin Dose for Depression; Add-On Schizophrenia Success; Genetic Suicidality

<ѻý class="mpt-content-deck">— News and commentary from the psychiatry world
MedpageToday
Illustration of a brain shaped maze.

Just (0.215 mg/kg body weight) -- commonly known as magic mushrooms -- was associated with a 13-point drop in depressive symptom severity versus placebo, lasting at least 2 weeks. (eClinicalMedicine)

Parental leave from work for postpartum mothers, especially paid leave for a minimum of 2 to 3 months, was . (Lancet Public Health)

Participants taking as add-on therapy to an antipsychotic for treatment-resistant schizophrenia continued to see improvement over 6 months compared with 6-week results, developer Newron Pharmaceuticals announced.

Filled prescriptions for declined among pregnant Medicaid beneficiaries from 2015 to 2019, although there was a modest uptick in prescription stimulant fills. (JAMA Pediatrics)

Over a third of beneficiaries of the U.S. military healthcare system live in , while 6% don't have any available psychiatrists even within a 30-minute drive. (JAMA Network Open)

Meanwhile, a genome-wide association study of U.S. military veterans found a . (JAMA Psychiatry)

Some patients say misleading ads from led to abuse of controlled substances like ketamine and drugs for attention-deficit/hyperactivity disorder. (Wall Street Journal)

Even so, more and more are popping up around the country. (NBC News)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.